Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study

Autor: Mato, Anthony R., Hess, Lisa M., Chen, Yongmei, Abada, Paolo B., Konig, Heiko, Pagel, John M., Walgren, Richard A.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia January 2023 23(1):57-67
Databáze: ScienceDirect